Having shown that anti-FXa APS-IgG had the greatest effect upon prolongation of FXa-dependent coagulation and enzymatic activity we then studied whether anti-FXa inhibit AT-III mediated inactivation of FXa. This evidence concerns the gene F10 and autoimmune polyendocrinopathy.